Long-acting and selective suppression of growth hormone secretion by somatostatin analogue SMS 201-995 in acromegaly (Q72589099)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6148524%20AND%20SRC:MED&resulttype=core&format=json

27 October 2019

title

Long-acting and selective suppression of growth hormone secretion by somatostatin analogue SMS 201-995 in acromegaly (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6148524%20AND%20SRC:MED&resulttype=core&format=json

27 October 2019

author name string

G. Plewe

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6148524

15 August 2023

J. Beyer

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6148524

15 August 2023

U. Krause

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6148524

15 August 2023

M. Neufeld

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6148524

15 August 2023

E. del Pozo

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6148524

15 August 2023

language of work or name

English

0 references

publication date

1 October 1984

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6148524%20AND%20SRC:MED&resulttype=core&format=json

27 October 2019

6 October 1984

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=6148524

full work available at URL

15 August 2023

https://api.elsevier.com/content/article/PII:S0140673684907062?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(84)90706-2

https://api.elsevier.com/content/article/PII:S0140673684907062?httpAccept=text/plain

15 August 2023

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(84)90706-2

15 August 2023

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6148524%20AND%20SRC:MED&resulttype=core&format=json

27 October 2019

volume

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6148524%20AND%20SRC:MED&resulttype=core&format=json

27 October 2019

issue

8406

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6148524%20AND%20SRC:MED&resulttype=core&format=json

27 October 2019

page(s)

782-784

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6148524%20AND%20SRC:MED&resulttype=core&format=json

Critical study of the growth hormone response to dynamic tests and the insulin growth factor assay in acromegaly after microsurgery

27 October 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2884%2990706-2

7 January 2021

Treatment of acromegaly by trans-sphenoidal operation, 90-yttrium implantation and bromocriptine: results in 230 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2884%2990706-2

7 January 2021

Hypothalamic Polypeptide That Inhibits the Secretion of Immunoreactive Pituitary Growth Hormone

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2884%2990706-2

7 January 2021

Action of growth-hormone-release inhibitory hormone in healthy men and in acromegaly

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2884%2990706-2

7 January 2021

Growth hormone release inhibiting hormone in acromegaly

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2884%2990706-2

7 January 2021

Effect of somatostatin in patients with acromegaly: suppression of growth hormone, prolactin, insulin and glucose levels

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2884%2990706-2

7 January 2021

Inhibition of insulin secretion by somatostatin

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2884%2990706-2

7 January 2021

Somatostatin: analogs with selected biological activities

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2884%2990706-2

7 January 2021

SMS 201–995: A very potent and selective octapeptide analogue of somatostatin with prolonged action

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2884%2990706-2

7 January 2021

Immunoassay of insulin with insulin-antibody precipitate

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2884%2990706-2

7 January 2021

Glucagon Radioimmunoassay Using Antiserum 30K: Interference by Plasma

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2884%2990706-2

7 January 2021

Somatostatin analogs which inhibit glucagon and growth hormone more than insulin release

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2884%2990706-2

7 January 2021

Dissociated effects of somatostatin analogs on arginine-induced insulin, glucagon and growth hormone release in acromegalic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2884%2990706-2

7 January 2021

A novel cyclic undercapeptide, WY-40, 770, with prolonged growth hormone release inhibiting activity

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2884%2990706-2

7 January 2021

Suppression of pancreatic endocrine tumour secretion by long-acting somatostatin analogue

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2884%2990706-2

7 January 2021

Effect of a Long-Acting Octapeptide Analogue of Somatostatin on Growth Hormone and Pancreatic and Gastrointestinal Hormones in Man

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2884%2990706-2

7 January 2021

Inhibition by somatostatin of ACTH secretion in Nelson's syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2884%2990706-2

7 January 2021

Effects of growth hormone release-inhibiting hormone and bromocryptine (CB 154) in states of abnormal pituitary-adrenal function

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2884%2990706-2

7 January 2021

Effects of somatostatin on the secretion of thyrotropin and prolactin

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2884%2990706-2

7 January 2021

SOMATOSTATIN-28 INHIBITS LHRH-STIMULATED GONADOTROPHIN SECRETION IN MAN

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2884%2990706-2

7 January 2021

Somatostatin, basic and clinical studies. A review

9

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(84)90706-2

An in vivo model for testing inhibition of arginine-induced insulin and glucagon release by somatostatin analogs

15 August 2023

15

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(84)90706-2

15 August 2023

Identifiers

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6148524%20AND%20SRC:MED&resulttype=core&format=json

27 October 2019

1 reference